Webinars

Companion Diagnostic Approaches in the Development of Cell and Gene Therapies

Sponsored by: Labcorp

5 +10pts

Speakers

Akanksha Gupta, PhD

Executive Director, Cell & Gene Therapy, Labcorp
BIOGRAPHY
Christos J. Petropoulos, PhD

Chief Scientific Officer, Monogram Biosciences and Vice President, Corporate Research and Development, Labcorp
BIOGRAPHY
Irene Bacalocostantis

Executive Director, Regulatory Affairs, Project and Portfolio Management and Manufacturing, Companion Diagnostics (CDx), Labcorp
BIOGRAPHY
Taylor Jensen, PhD

Vice President, Head of Oncology Science, Labcorp
BIOGRAPHY

Abstract

Watch the third of a three-part roundtable series that focus on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry insights from our cell and gene therapy scientists and operational leaders.

In this roundtable, the panel focus on the adoption of companion diagnostics strategies for your clinical cell and gene therapy development efforts. Specific areas of discussion include:

The evolving landscape of companion diagnostics in the field of cell and gene therapy
The role of anti-AAV neutralizing and total antibody assessment in clinical trials, including their potential as companion diagnostics for gene therapies
Regulatory considerations for the development of cell and gene therapies and trends with certain regulatory bodies
Considerations for commercializing a companion diagnostic

Watch roundtable 1: Key Considerations for Driving Gene Therapy Programs Successfully Through IND/CTA and Beyond
Watch roundtable 2: Accelerating Cell Therapy Clinical Trials With Comprehensive Biomarker-Driven Strategies
Watch roundtable 3: Companion Diagnostic Approaches in the Development of Cell and Gene Therapies

Companion Diagnostic Approaches in the Development of Cell and Gene Therapies

Akanksha Gupta, PhD

Christos J. Petropoulos, PhD

Irene Bacalocostantis

Taylor Jensen, PhD